TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding (T8/10SVB)
Primary Purpose
Decompensated Cirrhosis, Portal Hypertension, Bleeding Varices
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
8-mm covered stent group
10-mm covered stent group
Sponsored by
About this trial
This is an interventional treatment trial for Decompensated Cirrhosis focused on measuring transjugular intrahepatic portosystemic shunt, TIPS, liver cirrhosis, variceal bleeding, 8- or 10-mm covered stent
Eligibility Criteria
Inclusion Criteria:
- Cirrhotic patients with at least one episode of variceal bleeding
- No active bleeding within 5 days before TIPS
- Child-Pugh score ≤13
- Signed written informed consent
Exclusion Criteria:
- An age <18 years or >75 years
- With TIPS contraindications
- Past or present history of hepatic encephalopathy
- Pregnancy or breast-feeding
- Hepatic carcinoma and/or other malignancy diseases
- Sepsis
- Spontaneous bacterial peritonitis
- Uncontrollable hypertension
- Serious cardiac or pulmonary dysfunction
- Renal failure
- Portal vein thrombosis
- History of organ transplantation
- History of HIV (human immunodeficiency viruses) infection
Sites / Locations
- Xijing Hospital of Digestive Diseases, Fourth Military Medical University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
10-mm covered stent group
8-mm covered stent group
Arm Description
Patients treated with 10-mm covered stent.
Patients treated with 8-mm covered stent.
Outcomes
Primary Outcome Measures
Incidence of shunt dysfunction.
Secondary Outcome Measures
Incidence of variceal rebleeding
Incidence of hepatic encephalopathy
Survival
Incidence of hepatic myelopathy
Full Information
NCT ID
NCT01410591
First Posted
August 4, 2011
Last Updated
January 23, 2016
Sponsor
Air Force Military Medical University, China
1. Study Identification
Unique Protocol Identification Number
NCT01410591
Brief Title
TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding
Acronym
T8/10SVB
Official Title
The Effect of TIPS With 8- or 10-mm Covered Stent for Preventing Variceal Rebleeding in Cirrhotic Patients.
Study Type
Interventional
2. Study Status
Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
July 2012 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
January 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Air Force Military Medical University, China
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine whether transjugular intrahepatic portosystemic shunt (TIPS) with 10-mm covered stent is associated with lower shunt dysfunction in comparing TIPS with 8-mm covered stent in cirrhotic patients with at least one episode of variceal bleeding.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Decompensated Cirrhosis, Portal Hypertension, Bleeding Varices
Keywords
transjugular intrahepatic portosystemic shunt, TIPS, liver cirrhosis, variceal bleeding, 8- or 10-mm covered stent
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
127 (Actual)
8. Arms, Groups, and Interventions
Arm Title
10-mm covered stent group
Arm Type
Active Comparator
Arm Description
Patients treated with 10-mm covered stent.
Arm Title
8-mm covered stent group
Arm Type
Active Comparator
Arm Description
Patients treated with 8-mm covered stent.
Intervention Type
Device
Intervention Name(s)
8-mm covered stent group
Intervention Description
Creating a shunt between hepatic vein and portal vein with a 8-mm covered stent by TIPS procedure.
Intervention Type
Device
Intervention Name(s)
10-mm covered stent group
Intervention Description
Creating a shunt between hepatic vein and portal vein with a 10-mm covered stent by TIPS procedure.
Primary Outcome Measure Information:
Title
Incidence of shunt dysfunction.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Incidence of variceal rebleeding
Time Frame
2 years
Title
Incidence of hepatic encephalopathy
Time Frame
2 years
Title
Survival
Time Frame
2 years
Title
Incidence of hepatic myelopathy
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Cirrhotic patients with at least one episode of variceal bleeding
No active bleeding within 5 days before TIPS
Child-Pugh score ≤13
Signed written informed consent
Exclusion Criteria:
An age <18 years or >75 years
With TIPS contraindications
Past or present history of hepatic encephalopathy
Pregnancy or breast-feeding
Hepatic carcinoma and/or other malignancy diseases
Sepsis
Spontaneous bacterial peritonitis
Uncontrollable hypertension
Serious cardiac or pulmonary dysfunction
Renal failure
Portal vein thrombosis
History of organ transplantation
History of HIV (human immunodeficiency viruses) infection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guohong Han, PhD & MD
Organizational Affiliation
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
City
Xi'an
State/Province
Shaanxi
ZIP/Postal Code
710032
Country
China
12. IPD Sharing Statement
Citations:
PubMed Identifier
20537753
Citation
Riggio O, Ridola L, Angeloni S, Cerini F, Pasquale C, Attili AF, Fanelli F, Merli M, Salvatori FM. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol. 2010 Aug;53(2):267-72. doi: 10.1016/j.jhep.2010.02.033. Epub 2010 Apr 27.
Results Reference
background
PubMed Identifier
28506905
Citation
Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, Niu J, Guo W, Luo B, Yin Z, Bai W, Chen H, Wang E, Xia D, Li X, Yuan J, Han N, Cai H, Li T, Xie H, Xia J, Wang J, Zhang H, Wu K, Fan D, Han G. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol. 2017 Sep;67(3):508-516. doi: 10.1016/j.jhep.2017.05.006. Epub 2017 May 12.
Results Reference
derived
Learn more about this trial
TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding
We'll reach out to this number within 24 hrs